John M. Hilfinger
- Molecular Biology
- Oncology top 5%
- Pharmaceutical Science top 1%
- Infectious Diseases top 5%
- Organic Chemistry top 10%
- Co-authors
- Gordon L. AmidonYasuhiro TsumeBlake J. RoesslerElke WalterChristopher P. LandowskiBalvinder S. VigPhilip L. LorenziArik Dahan
- Topics
- Biochemical and Molecular Research (10 papers)HIV/AIDS drug development and treatment (10 papers)HIV Research and Treatment (8 papers)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
John M. Hilfinger
44 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 106
- Molecular Biology 641
- Oncology 507
- Pharmaceutical Science 331
- Infectious Diseases 297
- Organic Chemistry 175
Countries citing papers authored by John M. Hilfinger
This map shows the geographic impact of John M. Hilfinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Hilfinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Hilfinger more than expected).
Fields of papers citing papers by John M. Hilfinger
This network shows the impact of papers produced by John M. Hilfinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Hilfinger. The network helps show where John M. Hilfinger may publish in the future.
Co-authorship network of co-authors of John M. Hilfinger
This figure shows the co-authorship network connecting the top 25 collaborators of John M. Hilfinger. A scholar is included among the top collaborators of John M. Hilfinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Hilfinger. John M. Hilfinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 35 | |
| 3 | 10 | |
| 4 | 1 | |
| 5 | 12 | |
| 6 | 7 | |
| 7 | 63 | |
| 8 | 34 | |
| 9 | 62 | |
| 10 | 8 | |
| 11 | 14 | |
| 12 | 19 | |
| 13 | 58 | |
| 14 | 28 | |
| 15 | 51 | |
| 16 | 37 | |
| 17 | 20 | |
| 18 | 59 | |
| 19 | 23 | |
| 20 | 222 |
About John M. Hilfinger
John M. Hilfinger is a scholar working on Virology, Physiology and Biochemistry, having authored 44 papers that have together received 1.5k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (10 papers), HIV/AIDS drug development and treatment (10 papers) and HIV Research and Treatment (8 papers). The work is most often cited by research in Pharmaceutical Science (331 citations), Oncology (507 citations) and Infectious Diseases (297 citations). John M. Hilfinger has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Gordon L. Amidon, Yasuhiro Tsume, Blake J. Roessler, Elke Walter, Christopher P. Landowski, Balvinder S. Vig, Philip L. Lorenzi, Arik Dahan, Xueqin Song and Charles E. McKenna. Their work appears in journals such as Journal of Biological Chemistry, Gastroenterology and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.